Coffin–Siris syndrome and related disorders involving components of the BAF (mSWI/SNF) complex: Historical review and recent advances using next generation sequencing. Issue 3 (28th August 2014)
- Record Type:
- Journal Article
- Title:
- Coffin–Siris syndrome and related disorders involving components of the BAF (mSWI/SNF) complex: Historical review and recent advances using next generation sequencing. Issue 3 (28th August 2014)
- Main Title:
- Coffin–Siris syndrome and related disorders involving components of the BAF (mSWI/SNF) complex: Historical review and recent advances using next generation sequencing
- Authors:
- Kosho, Tomoki
Miyake, Noriko
Carey, John C.
Kosho, Tomoki
Miyake, Noriko - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ajmgc31415-sec-0001" sec-type="section"> <p>This issue of Seminars in Medical Genetics, <italic>American Journal of Medical Genetics</italic> Part C investigates the human diseases caused by mutations in the BAF complex (also known as the mammalian SWI/SNF complex) genes, particularly focusing on Coffin–Siris syndrome (CSS). CSS is a rare congenital malformation syndrome characterized by developmental delay or intellectual disability (ID), coarse facial appearance, feeding difficulties, frequent infections, and hypoplasia/aplasia of the fifth fingernails and fifth distal phalanges. In 2012, 42 years after the first description of CSS in 1970, five causative genes (<italic>SMARCB1</italic>, <italic>SMARCE1</italic>, <italic>SMARCA4</italic>, <italic>ARID1A</italic>, <italic>ARID1B</italic>), all encoding components of the BAF complex, were identified as being responsible for CSS through whole exome sequencing and pathway‐based genetic screening. The identification of two additional causative genes (<italic>PHF6</italic>, <italic>SOX11</italic>) followed. Mutations in another BAF complex gene (<italic>SMARCA2</italic>) and (<italic>TBC1D24)</italic> were found to cause clinically similar conditions with ID, Nicolaides–Baraitser syndrome and DOORS syndrome, respectively. Also, <italic>ADNP</italic> was found to be mutated in an autism/ID syndrome. Furthermore, there is growing<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="ajmgc31415-sec-0001" sec-type="section"> <p>This issue of Seminars in Medical Genetics, <italic>American Journal of Medical Genetics</italic> Part C investigates the human diseases caused by mutations in the BAF complex (also known as the mammalian SWI/SNF complex) genes, particularly focusing on Coffin–Siris syndrome (CSS). CSS is a rare congenital malformation syndrome characterized by developmental delay or intellectual disability (ID), coarse facial appearance, feeding difficulties, frequent infections, and hypoplasia/aplasia of the fifth fingernails and fifth distal phalanges. In 2012, 42 years after the first description of CSS in 1970, five causative genes (<italic>SMARCB1</italic>, <italic>SMARCE1</italic>, <italic>SMARCA4</italic>, <italic>ARID1A</italic>, <italic>ARID1B</italic>), all encoding components of the BAF complex, were identified as being responsible for CSS through whole exome sequencing and pathway‐based genetic screening. The identification of two additional causative genes (<italic>PHF6</italic>, <italic>SOX11</italic>) followed. Mutations in another BAF complex gene (<italic>SMARCA2</italic>) and (<italic>TBC1D24)</italic> were found to cause clinically similar conditions with ID, Nicolaides–Baraitser syndrome and DOORS syndrome, respectively. Also, <italic>ADNP</italic> was found to be mutated in an autism/ID syndrome. Furthermore, there is growing evidences for germline or somatic mutations in the BAF complex genes to be causal for cancer/cancer predisposition syndromes. These discoveries have highlighted the role of the BAF complex in the human development and cancer formation. The biology of BAF is very complicated and much remains unknown. Ongoing research is required to reveal the whole picture of the BAF complex in human development, and will lead to the development of new targeted therapies for related disorders in the future. © 2014 Wiley Periodicals, Inc.</p> </sec> </abstract> … (more)
- Is Part Of:
- American journal of medical genetics. Volume 166:Issue 3(2014)
- Journal:
- American journal of medical genetics
- Issue:
- Volume 166:Issue 3(2014)
- Issue Display:
- Volume 166, Issue 3 (2014)
- Year:
- 2014
- Volume:
- 166
- Issue:
- 3
- Issue Sort Value:
- 2014-0166-0003-0000
- Page Start:
- 241
- Page End:
- 251
- Publication Date:
- 2014-08-28
- Subjects:
- Medical genetics -- Periodicals
616.04205 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
- DOI:
- 10.1002/ajmg.c.31415 ↗
- Languages:
- English
- ISSNs:
- 1552-4868
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0827.940000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3468.xml